Podcasts about medical affairs

Welcome to Perimenopause WTF!, brought to you by ⁠Perry⁠—the #1 perimenopause app and education space. The Perry Academy was created for

In this episode, Peg Crowley-Nowick speaks with Joseph Elassal, MD, MBA, Chief Medical Officer of Ankyra Therapeutics, about the strategic, operational, and financial realities of leading clinical development from pre-IND through proof of concept and toward commercialization.   Drawing on experience across large pharma, biotech partnerships, and early-phase oncology, Joe shares a practical roadmap for new and aspiring CMOs. They discuss how to prioritize essential capabilities, including clinical operations, regulatory strategy, biostatistics, and pharmacovigilance, while determining the right time to introduce Medical Affairs. The conversation outlines how to scale teams at critical inflection points such as IND clearance, Phase 2 proof of concept, and advancement into Phase 3.   The episode also examines investor and board expectations, CRO selection, capital efficiency, cash runway management, and the performance metrics CMOs are ultimately judged on—from disciplined milestone execution to generating meaningful clinical data. This episode offers actionable insight for biotech founders, clinical development leaders, medical affairs professionals, and emerging CMOs navigating the path from early development to launch.

I am excited to welcome Dr. Jayne Morgan as my guest today. She is a cardiologist and the Vice President of Medical Affairs at Hello Heart, specializing in women's health and cardiovascular research. In our conversation, we look at the gaps in clinicians' training around perimenopause and menopause, also discussing gender neutral training, and how men and women are treated differently in the medical system. Dr. Morgan shares her preferred areas of focus when educating middle-aged women about hormone replacement therapy and clusters of diagnoses, which include diabetes, dyslipidemia, high blood pressure, and weight-loss resistance. We examine how myocardial infarctions (heart attacks) tend to manifest differently in women, often with microvascular disease, atypical chest pain, and less obvious symptom patterns. We also explore screening recommendations, such as EKGs, Lp(a) assessments, and mammography for microcalcifications, which might indicate an elevated risk for cardiovascular disease. This fun and lively conversation with Dr. Morgan offers valuable, practical insights into women's heart health. I look forward to recording future podcast episodes with her. IN THIS EPISODE, YOU WILL LEARN: One-size-fits-all treatment of women during medical training in the '90s and early 2000s Speaking up in the exam room when something doesn't feel right When hormone therapy was labeled dangerous, and the fallout that followed Medicine's uncomfortable truth: clinicians must keep learning or fall behind Gender-neutral cardiology and the women it left behind The midlife risk-factor pileup no one prepared women for  Why not taking blood pressure or cholesterol medications is risky rather than healthy Heart attacks often mistaken for anxiety, especially in women Slow change, real progress in women's cardiology care Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Connect with Dr. Jayne Morgan On Instagram, TikTok, Threads, YouTube, and LinkedIn

In this episode of Health Gig, Doro and Tricia welcome Dr. Eva Selhub, Chief of Medical Affairs at ForHumanity. Dr. Selhub talks about her journey within the medical field, which was shaped by personal experiences that led her to rethink traditional healthcare. Through her work at ForHumanity, she is an educator on personalized healthcare delivery and the significance of understanding bio-individuality. Dr. Selhub leaves listeners with the understating that while health comes from practice and medicines, true wellness stems from compassion and self-love.

Learning Objectives:After listening to this episode, the audience will be able to:  Describe how a Medical Affairs organization prioritized and implemented AI use cases to address HCP needs through faster, more intuitive, conversational engagement with medical content.Identify key considerations for scaling external-facing AI solutions in Medical Affairs, including compliance, governance, and long-term sustainability.

How Medical Affairs leaders can move their organizations from a supporting role to a strategic driver—through accountability, insight translation, and the smart use of AI. In this episode of Medical Affairs Unscripted, Peg Crowley-Nowick speaks with Greg Carpenter, Global Medical Strategy Leader in General Medicine at Sanofi, for a candid conversation on how Medical Affairs must evolve to remain relevant—and indispensable—in a rapidly changing industry. The discussion focuses on how Medical Affairs leaders can increase their strategic impact across pharma and biopharma organizations. Drawing on experience across commercial, quality, and Medical Affairs functions, Carpenter outlines why broader career paths, business acumen, and accountability are essential to creating Medical Affairs value. The conversation examines how Medical Affairs can move beyond data delivery to translate medical insights into strategy, strengthen cross-functional collaboration, and better support physicians and patients. The episode concludes with a practical discussion on AI in Medical Affairs, including how AI is being used today to improve insights, content development, and efficiency—while reinforcing the importance of human judgment and leadership.

Send us a textDr. Chris Oswald, DC, CNS, is Head of Medical Affairs for Pure Encapsulations ( https://www.pureencapsulations.com/ ), part of Nestlé Health Science family. He is a chiropractor, certified nutrition specialist and certified functional medicine practitioner and has been treating patients since 2007. At Pure Encapsulations, Dr. Oswald leads medical education, scientific strategy, and innovation across well-known professional brands including Pure Encapsulations, Douglas Labs, Klean Athlete, Genestra, and others. In this role, he sits at the intersection of clinical science, practitioner education, and product innovation — translating complex evidence into practical tools that help healthcare professionals practice more confident, personalized nutritional medicine. Dr. Oswald's clinical work, in combination with his work in professional dietary supplement companies, gives him unique insight into the creation of clinically useful tools and education to support the unique needs of clinicians and patients in functional, integrative and natural health.Before joining Pure Encapsulations, Dr. Oswald held senior leadership roles across the nutraceutical and health tech landscape, including Chief Science Officer, Head of Product Innovation and R&D, Head of Operations, Interim Head of Sales, and VP of Nutraceuticals at companies like January AI and Further Food. Across those roles, he's led everything from supply chain and regulatory strategy to product development, claims substantiation, and national practitioner education.At the core of Dr. Oswald's work is a consistent theme: bridging rigorous science, real-world clinical practice, and responsible commercialization — all with the goal of improving patient outcomes and advancing the future of personalized, integrative healthcare.#ChrisOswald #PureEncapsulations #NestleHealthScience #FunctionalMedicine #Nutrition #DietarySupplements #Nutraceuticals #PureGenomics #DeniseFurness #Nutrigenomics #Genetics #Epigenetics #PersonalizedHealth #BiologicalAgeProtocol #BiologicalAging #Telomeres #Proteomics #Metabolomics #Biomarkers #Glycans#STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

'One FM' by One MSL strives to connect voices within the global Field Medical community.For episode 15 Helen was joined by Nuria Marcos, Regional Medical Affairs Director, Menarini.If you would like to feature on a future episode, please email community@onemsl.comhttps://www.onemsl.com/

For years, patient involvement in drug development was limited to trial participation and post-approval education. But things are evolving. Patients today aren't just participants—they actively co-build the healthcare ecosystem.In today's podcast episode, experts from the MAPS Scientific & Technical Knowledge Domain dive into a topic that's transforming clinical development: Patient engagement.

Did you know that nearly 50% of women experience hair changes during menopause? In this expert-led conversation, we uncover the truth behind menopausal hair thinning, shedding, and texture changes with Dr. Isabelle Raymond, SVP of Clinical and Medical Affairs at Nutrafol. Dr. Raymond is dedicated to advancing women's health, with a particular focus on the biological and lifestyle factors that impact hair health during midlife. We explore the six root causes of hair thinning, the critical role of nutrition and hormones in hair growth, and why clinically backed research is essential for proven hair wellness solutions. Show Notes/Links: www.hotflashescooltopics.com Nutrafol: Link WE GREATLY APPRECIATE 5 STARS AND REVIEWS! Find Us Here! Website I [http://hotflashescooltopics.com/] Mail I [hotflashescooltopics@gmail.com] Instagram I [https://www.instagram.com/hotflashesandcooltopics/] Facebook : [www.facebook.com/hotflashescooltopics] YouTube I [https://www.youtube.com/@HotFlashesCoolTopics] Pinterest I [https://www.pinterest.com/hcooltopics/]

In this episode, Dr. Sriram Vissa, Chief Medical Officer and Vice President of Medical Affairs at SSM Health DePaul Hospital, shares how multidisciplinary teamwork and data driven care progression improved safety, efficiency, and length of stay, while outlining priorities for behavioral health access, workforce stability, and growth in 2026.

In the first episode of our series on innovation in Medical Affairs, we focused on the mindset that allows ideas to flourish and on why innovation matters at all. So where do we go from here...How do we move from ideas to implementation? How do we build systems that make innovation repeatable, measurable, and scalable?In today's podcast episode, experts from the MAPS Leadership and Management Domain dive deep into the topic of how to convert great ideas into real world value for patients, physicians, and in general, the health care ecosystem.

Your heart attack won't look like the movies—and that ignorance is killing women. Dr. Jayne Morgan, renowned cardiologist and VP of Medical Affairs at Hello Heart, shares a shocking truth: women wait 37 minutes longer for care than men, and each minute increases your risk of dying. Discover why fatigue and jaw pain might be your body's SOS, how menopause impacts your natural heart protection, and the one phrase that gets immediate ER attention. Heart disease is women's #1 killer, yet we're dismissed as "atypical." Arm yourself with knowledge that saves lives, beauties—starting now. FOLLOW A CERTAIN AGE ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ GET INBOX INSPO: Sign up for our newsletter ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠AGE BOLDLY⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We share new episodes, giveaways, links we love, and midlife resources Learn more about your ad choices. Visit megaphone.fm/adchoices

Medical Affairs is evolving faster than ever. It demands not only execution, but imagination. In fact, innovation in Medical Affairs isn't just needed. It's already happening, and we have the responsibility to guide it with intention.In today's podcast episode, our speakers explore the foundations of innovation and how having an innovative mindset can help fuel a curious and collaborative Medical Affairs organization to reach new goals.

Access to contraception can shape health, autonomy, and opportunity, but what does it really take to safely expand that access? In this episode, we're joined by Dr. Stephanie Sober, OB-GYN and Global Director of Medical Affairs at Perrigo Women's Health, to explore the landmark approval of Opill, the first daily oral contraceptive available over the counter in the U.S. Tune in to hear how nearly a decade of research and regulatory work made this switch possible, how the FDA evaluates real-world use without physician supervision, and why over-the-counter contraception is a major step forward for reproductive health equity.Dr. Stephanie Sober is an OB-GYN physician and the Global Director of Medical Affairs at Perrigo Women's Health. She co-led the studies submitted to the FDA to support Opill's transition from prescription-only to over-the-counter status and has worked closely with medical organizations, regulators, and reproductive health advocates to expand safe, evidence-based access to contraception.

Dr. Ryan Gober, Medical Science Liaison at Electromedical Products International (EPI). Dr. Gober shares his insights on the science behind Alpha-Stim, its clinical applications for anxiety, insomnia, and pain, and the role of non-invasive brain stimulation in mental health treatment.Electromedical Products International (EPI) is a medical device company specializing in developing neuromodulation technologies including its flagship product, Alpha-Stim.   Alpha-Stim is a FDA cleared medical device which utilizes a form of non-invasive electrical stimulation  to treat symptoms of anxiety, insomnia, and pain.  Ryan Gober is a Medical Science Liaison with EPI's Medical Affairs team responsible for sharing scientific and clinical information related to the Alpha-Stim device.  Prior to joining EPI, Ryan completed an NIH research fellowship followed by a PhD in translational neuroscience where he performed research on behavioral health conditions and developed an interest in non-pharmacological options for treating mental health conditions, leading him to join Alpha-Stim.  SHOWNOTES: 

In this episode, Denise J. Jamieson, MD, MPH, Vice President for Medical Affairs and Dean of the Carver College of Medicine at University of Iowa Health Care, shares her journey from the CDC to academic leadership, the mission of serving Iowa, and her priorities around physician workforce development, mentorship, and sustaining impact in healthcare.

Feeling tired and washed out? It could be more than fatigue. Lori Hartwell and Dr. Todd Minga, Vice-President of Clinical Research and Medical Affairs at Akebia Therapeutics uncover how anemia and kidney disease intertwine"and why understanding this hidden link could change how you manage your health.

In this episode of Dana Tech Talks, Dana Moreau speaks with Anastasia Albanese-O'Neill, Vice President of Medical Affairs at Breakthrough T1D, about the critical role clinical trials play in advancing type 1 diabetes care. They explore emerging therapies, growing screening efforts, and practical tools that help clinicians connect patients to research opportunities. Together, they highlight how building a culture of trial participation can accelerate progress toward T1D cures. Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast. Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

About Trudy McKanna:Trudy McKanna is an accomplished medical affairs leader with extensive experience across medical education, field medical strategy, and people management. Currently serving as Senior Field Medical Director at GRAIL, she brings more than two decades of expertise spanning oncology, organ health, genetics, and medical ethics. Prior to GRAIL, she spent nine years at Natera in progressively senior roles, including Senior Director of Medical Affairs for Organ Health, where she led medical strategy, built and managed high-performing teams, and shaped national KOL engagement efforts across transplant and renal genetics. Her background includes over a decade as a genetic counselor and supervisor at Spectrum Health, leadership roles in professional organizations such as the Michigan Association of Genetic Counselors, and academic appointments with Michigan State University. As co-founder and vice president of the Rockford Food Allergy Network, she also helped strengthen community education and advocacy around food allergy awareness. Trudy holds a Master of Science in Genetic Counseling from the University of Michigan and a Bachelor of Science in Biology/Biochemistry from Hope College.Things You'll Learn:Early detection significantly changes survival outcomes; identifying cancer before it metastasizes can quadruple five-year survival rates.Multi-cancer early detection utilizes cell-free DNA and methylation patterns to detect signals from over 50 cancers with a simple blood draw.Adding this test to standard screening results in seven times more cancers being found, with over half detected at early stages.The false-positive rate is exceptionally low at 0.4%, making it viable for population-scale screening.Access and equity improve significantly when screening can be conducted in primary care settings, mobile units, employer sites, and underserved communities.Resources:Connect with and follow Trudy McKanna on LinkedIn.Follow GRAIL on LinkedIn and visit their website.Learn more about Galleri here.

Transforming your health is more fun with friends! Join Chef AJ's Exclusive Plant-Based Community. Become part of the inner circle and start simplifying plant-based living - with easy recipes and expert health guidance. Find out more by visiting: https://community.chefaj.com/ For a list "The Top 10 Things Having Cancer Has Taught Me" please email help@ChefAJ.com Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. To book a consultation with Matt: https://form.jotform.com/241997228318164 Matthew Lederman, MD, is a board-certified Internal Medicine Physician and leading innovator in holistic health. Known for integrating plant-based nutrition, Nonviolent Communication (NVC), trauma-informed care, and lifestyle medicine, he emphasizes the deep connection between physical, emotional, and relational well-being. A certified NVC Trainer through the Center for Nonviolent Communication (CNVC), Dr. Lederman blends Polyvagal Theory, Somatic Awareness, and Pain Reprocessing to help people address root causes of chronic health issues, build emotional resilience, and strengthen meaningful connections. He co-hosts the webe Parents podcast and is the author of Wellness to Wonderful, which unites medical science, psychology, spirituality, and life wisdom to guide individuals toward lasting health and joy. He also co-founded Kinectin, an AI-driven platform for cultivating deeper, more fulfilling relationships. Dr. Lederman has co-authored six books—including the New York Times bestseller Forks Over Knives Plan—and appeared in the acclaimed documentary Forks Over Knives. He has served as Vice President of Medical Affairs at Whole Foods Market, lectured for eCornell, taught in medical schools, and co-created the webe kälm device for emotional regulation. As co-founder of Connection Docs, he integrates NVC and emotional health with practical, science-backed tools that foster resilience, balance, and meaningful relationships for individuals and families. Email (questions & requests): Support@ConnectionDocs.com Website: https://www.connectiondocs.com/ Free Resources (includes Feelings & Needs Sheet for children AND Role-Play Video “Talking to Your Child About ‘Too Much' Device Time”) : https://www.connectiondocs.com/resources Substack (Weekly Articles on Connection): https://substack.com/@connectiondocs Breath & Body Regulation Training Tool: https://webekalm.com/ webe Pärents Podcast https://webekalm.com/pages/webeparents AI Connection Coach:https://app.kinectin.com/signup Main Book WELLNESS TO WONDERFUL: 9 Pillars for Living Healthier, Longer, and with Greater Joy: https://www.amazon.com/dp/B0C2S1JGZK?ref=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&ref_=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&social_share=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&starsLeft=1&skipTwisterOG=1&bestFormat=true Children's E-Books (Supporting Children Bringing More Connection Into Their Lives): Healing Shame and Connecting to Self-Worth and Intrinsic Value: https://webekalm.com/products/lily-and-her-beautiful-flower Being Honest with Care https://webekalm.com/products/ella-and-the-two-gifts-ebook Supporting Children During Emergencies (fires, earthquakes, etc):'https://webekalm.com/products/brave-hearts-facing-the-fire-ebook Social Media: Instagram: https://www.instagram.com/TheConnectionDocs Substack Newsletter: https://connectionDocs.substack.com Facebook: https://www.facebook.com/connectionDocs X: https://x.com/connectionDocs

In this podcast, lead by members of the MAPS Business Knowledge Domain, our experts will:Recognize marketing terminology and implications for Medical Affairs activitiesIdentify the relevance of market analysis for business decision-makingDefine the importance of competitor analysis and forecasting in marketing and salesRecall the value of cross-functional perspectives in decision-makingOutline the consequences of non-compliance in pharmaceutical activitiesProvide a perspective on how Medical Affairs can bring value to marketing and sales organizations

This three-part podcast explores how Medical Affairs leaders can navigate and lead through disruption with clarity, structure, and resilience.We explore how to construct and lead an agile, cross-functional crisis team. From defining roles to ensuring aligned decision-making across Medical, Regulatory, and Commercial functions, this episode emphasizes rapid coordination, internal trust, and shared accountability under pressure.

Bayer is reshaping its pharmaceutical business with a new operating model designed to enhance collaboration and bring research & development and commercialization closer together. In a recent episode of The Top Line podcast, Bayer executives Christine Roth, Executive Vice President and Head of Global Product Strategy and Commercialization, and Dr. Yesmean Wahdan, Head of Medical Affairs for the United States and North America, discussed how the company’s Dynamic Shared Ownership framework is driving faster innovation and helping accelerate the development of new therapies for patients. The model removes traditional hierarchies, empowers cross-functional teams and encourages real-time collaboration across departments. Roth and Wahdan said the approach has already shortened regulatory timelines, reduced resource use and helped deliver treatments to patients sooner. By embedding commercial insights early in the research process, Bayer teams can anticipate market needs and focus on the greatest areas of unmet medical demand. The leaders said the company’s collaborative culture keeps patient benefit at the center of decision-making. To learn more about how Bayer’s model is transforming its pipeline, listen to the full episode of The Top Line. See more from Bayer’s Christine Roth and Dr. Yesmean Wahdan on their LinkedIn profiles below: Christine: https://www.linkedin.com/in/christine-roth-34b07b18/ Yesmean: https://www.linkedin.com/in/yesmean-h-wahdan-md-71409b199/ See omnystudio.com/listener for privacy information.

Dr Ian Day has over 25 years of experience in the medical field, and currently serves as Medi-Share/Christian Care Ministry’s Chief Medical Officer (CMO) and Vice President of Medical Affairs. In this role, he leads Medi-Share’s clinical initiatives and ensures compassionate, comprehensive care for its members. Dr. Day has been a Central Florida resident since the 1990s, and serves as an elder at a church in Cape Canaveral. He enjoys spending time with his wife visiting their grandchildren, travelling, SCUBA diving, and beekeeping. To learn more about Dr Day, see his LinkedIn profile at https://www.linkedin.com/in/ian-day-md-cpe-faafp-08194148 To learn more about Medishare, see medishare.com Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.

Join Gary Rothenberg, DPM, CDCES, CWS, and Jodi Lavin Tompkins, MSN, RN, BC-ADM, CDCES, for an insightful discussion on diabetes-related peripheral neuropathy. Dr. Rothenberg explores the clinical manifestations, risk factors, and diagnostic approaches to neuropathy, while highlighting strategies for effective patient engagement and self-care support. The conversation also introduces the pyramid of treatments and therapies—a practical framework to guide interventions for individuals affected by neuropathy. Tune in to enhance your understanding of diabetes-related peripheral neuropathy and access the accompanying patient education handout designed to support self-management and shared decision-making. This episode is supported by an education grant from Lexicon Pharmaceuticals. Disclosure: Gary is Director of Medical Affairs, Podimetrics, makers of an FDA device to measure for prevention of diabetes-related foot ulcer recurrence. Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Medical Affairs isn't a downstream function—it's the throughline connecting science, story, and strategy from development through commercialization. This episode features Howard Rutman, MD, MBA, Chief Medical Officer at Xalud Therapeutics and Peg Crowley-Nowick, PhD, MBA discussing the critical role of early Medical Affairs engagement. Key topics include how early Medical Affairs involvement speeds patient enrollment and data generation, qualities to seek in the first Medical Affairs hire, the value a lean team can bring to BioTech, and the importance of evidence plans that support physician and market access needs.  The podcast emphasizes Medical Affairs as a continuous link from development to commercialization.

As Medical Affairs leaders, we are tasked with optimizing MA operations and talent through an increasingly multi-generational workforce. Several authors have addressed this issue. This podcast will discuss some of the common issues we are noticing around this topic, and bring relevant applications and examples to the Medical Affairs world, with the aim of understanding and optimizing the skills and contributions of all MA professionals.References & ResourcesGentelligence: The Revolutionary Approach to Leading an Intergenerational Workforce by Megan GerhardtTEDx Talk: Why I Love Millennials (and Why You Should Too) by Megan Gerhardt Amy Edmonson on Psychological Safety Google's re:Work – tools for psychological safety and team dynamicsTED Talk: Good Leaders Make People Feel Safe by Simon SinekTED Talk: The Danger of a Single Story by Chimamanda Ngozi AdichieOriginals: How Non-Conformists Move the World by Adam GrantBrené Brown — Brown, B. (2018). Dare to lead. Vermilion. https://brenebrown.com/hubs/dare-to-lead/Simon Sinek's TED Talk: Good Leaders Make People Feel SafeGo to https://medicalaffairs.org/knowledge-center/ for every reference in today's episode!

The future of aesthetics isn't just about smoothing lines—it's about stimulating regeneration and optimizing long-term skin health. In this episode of The Technology of Beauty, Dr. Grant Stevens interviews Bill Andriopoulos, VP Medical Affairs at Galderma, to explore how science is reshaping aesthetic medicine.Bill Andriopoulos walks us through Galderma's evolving approach to innovation, including its focus on real-world outcomes, diverse patient populations, and cutting-edge technologies such as biostimulatory HA fillers. With a career that spans both scientific research and medical strategy, he brings a unique lens to how the company designs, tests, and refines its global portfolio.You'll hear how Galderma is approaching regenerative aesthetics, why combination therapies are key to personalized outcomes, and what it takes to translate breakthrough science into tools that providers can trust. From molecule to market, this episode covers it all.If you're curious about what's next in aesthetics—and who's making it happen—this conversation is not to be missed.» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/» Instagram | thetechnologyofbeauty https://www.instagram.com/thetechnologyofbeauty/» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level.Subscribe here: https://www.influxmarketing.com/next-level-practices/» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/» Instagram | https://www.instagram.com/thetechnologyofbeauty/» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/

On this episode of the IPhO Podcast, we're spotlighting the inspiring journey of Dalila Masic, PharmD, Regional Medical Director - T1D Immunology at Sanofi. In this conversation with host Alena Abraham, PharmD, Dalila shares her path from completing PGY1 and PGY2 residencies in critical care at Loyola Medicine to beginning her industry career as a Medical Science Liaison in cardiovascular medicine and how she progressed into her current role, where she leads a team of 10 MSLs focused on autoimmune type 1 diabetes. She reflects on her transition from clinical practice to industry, the transferable skills that supported her pivot, and her leadership philosophy when coaching her team: anchored in clarity, curiosity, and confidence. Dalila also debunks myths about Medical Affairs, offers actionable advice for breaking into pharma without a fellowship, and shares strategies for students and early-career professionals to build credibility via science communication, curiosity, and networking. Whether you're exploring Medical Affairs for the first time or seeking leadership insights to guide your path, this episode delivers perspective and inspiration you won't want to miss!

In today's rapidly evolving healthcare landscape, leadership in the pharmaceutical industry is entering a new era—one defined by innovation, agility, and purpose-driven impact. This transformation is especially visible in Medical Affairs, where the role is shifting from traditional scientific support to becoming a strategic driver of patient-centered value, cross-functional collaboration, and real-world evidence generation. In this special series, Bagrat Lalayan sits down with prominent industry leaders to explore how modern leaders are navigating global challenges, embracing digital transformation, and redefining success in a more complex and regulated environment. Together, they'll discuss the skills, mindsets, and strategies required to lead with vision, foster trust, and accelerate innovation—while keeping patient outcomes at the heart of every decision.

Today on From Lab To Launch, we're excited to welcome Dr. Terrance Govender, the VP of Medical Affairs at ClinIntell.ClinIntell, based in Tampa, Florida, supports healthcare executives and leaders in accurately capturing the true severity of their inpatient population using population-based predictive analytics. The results for their customers? More accurate, trustworthy performance data and clinical condition reporting, that can be easily shared and used to drive continuous improvement activities. Qualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez

In the 2025 Payer Oncology Trend Report, we analyze how health plans and PBMs are navigating the shifting landscape of branded cancer drug management. To deepen our findings, we spoke with industry experts Michael Kolodziej, MD, and Ira Klein, Vice President, Medical Affairs & Payer Relations at Tempus, who shared their perspectives on the data, key trends, and what these insights mean for manufacturers moving forward.

On this episode of Alloutcoach, host Tim Mikhelashvili, CEO, Amedea Pharma convenes a panel you rarely hear in one room: a policy-minded biohacker and investor (John Hemming, CEO of Cirrostratus, Biohacking Team Leader), a strategy and operations leader who reshapes patient journeys (Bart Zoni, Senior Vice President, Marketing, Woven Health Collective), and an early-stage investor focused on medical technologies (Chris Piedmonte, Managing Director, Neoterra Capital) as well as a senior pharma thought leader in Medical Affairs and Health Economics, Janelle Hardisty. Their catalyst? Fresh takeaways from the 2025 Financial Times US Pharma summit — and an honest look at what's truly accelerating innovation, what's stalling it, and where capital and talent should go next.00:00:00 Cold Open - Episode Highlights: AI accuracy and access00:03:43 Host Intro and Why This Episode00:04:41 Guest Intros00:08:06 State of Innovation - Tailwinds and Headwinds00:12:41 What's Really Accelerating Innovation?00:19:27 Drug Discovery - Reducing the 90% Failure Rate00:22:01 Clinical Trials - Modernize or Stall00:25:11 Access, PBMs, and Direct-to-Patient00:27:03 Longevity and Prevention - Can We Measure It?00:36:52 Data Culture Maturity and Pilot Fatigue00:45:52 Training the Future Workforce00:51:09 Investing - Where Should Capital Flow?00:57:08 Regulatory Reality and Time-to-Access00:59:27 Closing and Invite to Medical Innovation Olympics

Experts Dr. Jeffrey Curtis and Dr. Kevin Winthrop discuss best practices for shared decision-making, how to talk with patients about the risks of poorly controlled RA, and ways to use a new tool for visualizing the long-term safety of a JAKi.

This episode features a powerful discussion with Dr. Padma Mahant, Director of Medical Affairs, CND Life Sciences, and Dr. Indu Subramanian, a Neurologist with UCLA, who are leading the charge to correct the biases in Parkinson's disease care. They expose a critical gap where women's unique, non-motor symptoms are often overlooked, resulting in twice as many women waiting five or more years for a proper diagnosis compared to men. The conversation highlights the imperative to move beyond the "cookie-cutter" approach by leveraging new, objective diagnostic tools to aid early detection, prioritizing women's inclusion in clinical research, and adopting a compassionate, integrative model that places the patient at the center of their own wellness journey. This podcast is not available for CME/CE/CPD credits. Please visit the Medscape homepage for accredited CME/CE/CPD activities. https://www.medscape.org/viewarticle/1002954

This episode features Dr. Jaideep Banerjee, Director of Global Clinical & Medical Affairs at Smith+Nephew, discussing the challenges of chronic wound care, the importance of standardized evidence-based practices, and insights from his recent large-scale study on enzymatic debridement. Dr. Banerjee shares strategies for improving patient outcomes, reducing costs, and building a strong foundation for long-term healing.This episode is sponsored by Smith+Nephew.Important Safety InformationIndication: Collagenase SANTYL Ointment (“SANTYL”) is indicated for debriding chronic dermal ulcers and severely burned areas. Contraindications: SANTYL is contraindicated in patients who have shown local or systemic hypersensitivity to collagenase. Warnings and Precautions: The optimal pH range of collagenase is 6 to 8. Higher or lower pH conditions will decrease the enzyme's activity and appropriate precautions should be taken. The enzymatic activity is also adversely affected by certain detergents, and heavy metal ions such as mercury and silver which are used in some antiseptics. As such, the wound should be properly cleansed prior to application of SANTYL. Debilitated patients should be closely monitored for systemic bacterial infections because of the theoretical possibility that debriding enzymes may increase the risk of bacteremia. A slight transient erythema has been noted occasionally in the surrounding tissue, particularly when SANTYL was not confined to the wound. SANTYL is not indicated for wound closure. Discontinue use of SANTYL after granulation tissue is well-established. Adverse Reactions: No allergic sensitivity or toxic reactions have been noted in clinical use when used as directed. The risk information provided herein is not comprehensive. To see the complete Prescribing Information, please see the FDA-approved product labeling, here: https://www.santyl.com/pdf/SANTYL-PI.pdf. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

In this episode of IDEA Collider, we are joined by Alex Telford, a biotech founder, writer, and thinker based in the San Francisco Bay Area. As the co-founder of Convoke Bio, Alex discusses his journey from studying biochemistry at UCL to founding a company that develops software tools for streamlining biopharmaceutical workflows.The conversation dives into the impact of AI and language models on the biotech industry, addressing inefficiencies in drug development, and exploring the potential of synthetic biology and personalized medicine. The discussion also touches on the future of drug discovery, China's role in biotech, and the challenges of understanding neuroscience and consciousness. Don't miss this insightful discussion on the future of biopharma innovation! 00:00 Welcome to Idea Collider00:04 Introducing Alex Telford01:59 Alex's Journey from UCL to Convoke Bio05:29 The Mission and Work of Convoke Bio07:57 Challenges in Pharma Decision Making14:05 The Role of AI in Pharma18:26 Knowledge Management and AI27:58 Staying Updated in the Fast-Moving AI Field30:25 AI's Impact on Industry Economics31:38 AI in Clinical Trials and Drug Development35:56 China's Role in Drug Discovery39:24 Neuroscience and AI: Blurring the Lines46:05 Future Predictions in Pharma51:20 Addressing Cognitive Bias in Pharma53:13 Concluding Thoughts and Future Directions Keep up with Alex Telford;LinkedIn: https://www.linkedin.com/in/alexander-telford/Website: atelfo.github.ioX: https://twitter.com/atelfoSubstack: atelfo.substack.com Follow Mike Rea On;Website: https://www.ideapharma.com/X: https://x.com/ideapharmaLinkedIn: https://www.linkedin.com/in/bigidea/ Listen to more fantastic podcast episodes: https://podcast.ideapharma.com/

In this episode, Kevin Kelleher (Director of Medical Affairs at Medtronic & founder of the Rural Health Technology Consortium) shares his journey from nurse to sales leader, and why passion, and not just money, must drive your career.Kevin's story really stuck with me. He went from nursing into sales, but what makes his perspective different is how he ties everything back to passion and purpose. He also opens up about what it's like serving rural communities, the push for more diversity in clinical research, and even how he balances leadership with family life. Honestly, it's one of those conversations that leaves you rethinking your life. From breaking into medical sales, building trust in rural healthcare, and tackling diversity in clinical research, to leadership, productivity, and family balance... Kevin brings powerful lessons you can apply today.

Before she turned eight, Cerys had already faced two diagnoses, only one of which she truly understood. While being diagnosed with celiac disease as a child, unusually high CK levels in her blood pointed to a deeper issue: limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). In this episode of On Rare, David Rintell, Head of Patient Advocacy at BridgeBio, and Mandy Rohrig, Senior Director of Patient Advocacy at BridgeBio Gene Therapy, speak with Cerys, a 23-year-old living in Wales, about living with LGMD2I/R9. She shares how she's navigated symptom progression, adapted to using mobility aids, and discovered the power of telling her story through her podcast, Unbalanced. When Cerys was first diagnosed with LGMD2I/R9 at age seven 7 years old, she didn't fully understand the diagnosis. Her parents carried the emotional weight, trying to protect her from fear of what was ahead. It wasn't until her muscle weakness became impossible to ignore, at 12 years old, that the condition began to define her daily life. From navigating stairs and driving to embracing a wheelchair, Cerys has had to adapt physically, emotionally, and socially, all while managing her energy levels so that she can continue to do the activities she loves. She finds strength in the LGMD community and hope in research, representation, and connection. In 2023, she launched Unbalanced to amplify stories like hers because growing up, she didn't see anyone with a disability who looked like her. Now, she's determined to be that voice for others. Dr. Anna Talaga, Director of Medical Affairs at ML Bio Solutions (a BridgeBio affiliate), provides a medical overview of LGMD. LGMDs are a group of genetic diseases that cause progressive muscle weakness and wasting, particularly in the shoulders, hips, and thighs. In some people, the heart and respiratory muscles may be impacted. Unlike many genetic conditions that are caused by a mutation in a single gene, LGMD can result from mutations in many different genes because they all affect the same protein complex that supports and stabilizes muscle fibers. LGMD type 2I/R9 (LGMD2I/R9), specifically, is caused by mutations in the FKRP gene, which is critical for maintaining muscle fiber integrity. Diagnosis typically begins with symptoms like difficulty walking, climbing stairs, or standing from a seated position, and is confirmed through genetic testing. LGMD2I/R9 is a progressive disease and there are currently no approved treatments that slow or stop its progression.

Abdul Hameed joins me on 5 in 5 to share how Medical Affairs acts as the bridge between science, patients, and commercial success. In just five minutes, we break down five actionable lessons you can use right now—from measuring real impact, to designing with patients, to applying AI responsibly.Quick, practical, and ready to implement. 

The effort to deport is expanding, as Nebraska agrees to help with immigration enforcement, creating a new detention facility dubbed "the Cornhusker Clink." Restoring law and order at the border was a big campaign promise of President Trump, and now CBP data show border apprehensions have hit new lows. Nebraska Governor Jim Pillen joins the Rundown to discuss the Trump administration's efforts in reeling in illegal immigration. There's a presidential push to lower drug prices, which are not only higher than in other countries but can vary from one pharmacy to the next. President Trump sent letters to 17 different pharma companies asking them to commit to cutting drug prices by September 29th. CEO of the Accreditation Council for Medical Affairs, Dr. William Soliman, joins the podcast to talk about this price-cutting deadline and why Americans pay so much more for prescription drugs. Plus, commentary from FOX News Contributor Joe Concha. Photo Credit: AP Learn more about your ad choices. Visit podcastchoices.com/adchoices

What does “great” Medical Affairs look like in 2025? We talk evidence, access, patient voice, and how to work with Commercial without crossing the promotional line. Abdul Hameed Al-Khateeb, Country Medical Director, shares practical lessons on measurement, real-world evidence, and where AI actually helps.Email to your listSubject line options (pick one):Inside Medical Affairs: From Evidence to AccessThe Missing Link Between Science and PatientsWhat Great Medical Affairs Looks Like (and How to Measure It)

About this episode:  Sickle cell disease affects an estimated 100,000 people in the United States. Recent advancements in gene therapies and medicines like hydroxyurea are diminishing extreme pain, reducing strokes, and extending survival times for those afflicted by the disease. In this episode: leading sickle cell disease expert Dr. Mark Gladwin explains how revolutionary new treatments work and discusses the challenges to access to life-saving care. Guest: Dr. Mark Gladwin is a physician-scientist and the Dean of the University of Maryland School of Medicine and Vice President for Medical Affairs at the University of Maryland, Baltimore. His research focuses include sickle cell disease and hypertension. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle—CNBC Gene Therapy: What You Need to Know—Sickle Cell Disease Association of American No More Pain: Breakthrough Sickle Cell Treatment from Johns Hopkins Offers Curative Potential—Johns Hopkins School of Medicine Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

It’s no secret that our lifespans – especially women’s – have drastically increased over the last several decades, but what about healthspans? How can we make those additional years healthier and happier? Speaking live at City Winery in NYC, join Katie and Dr. Krys Araujo-Torres, Head of U.S. Medical Affairs for Nature's Bounty, as they dig into the simple, effective steps we can take to live our best lives. #adSee omnystudio.com/listener for privacy information.

Being a pharmacist is exciting–as long as you're willing to try new things. These are wise words from my returning guest on today's podcast, who has been paving the way for integrative pharmacy. Dr. Swathi Varanasi is an award-winning pharmacist passionate about the intersection of personalized medicine, patient outcomes, and innovation. With experience spanning patient care, biotech, research, academia, and consumer product goods, Dr. Swathi has paved the way for healthcare professionals to pursue non-traditional career paths through creating postdoctoral training programs, industry internships, and online educational programs. She co-founded and serves as Chief Scientific Officer of the Life Sciences Division at Element Apothec, and serves as a Principal Investigator at contract research organization, Citruslabs. Dr. Swathi received her Doctor of Pharmacy (PharmD) at the Medical University of South Carolina and Bachelor of Arts (BA) at Carleton College. She was the first-ever pharmacist in the United States with formal residency training to specialize in integrative medicine and preventative health. She also completed a postdoctoral fellowship in Medical Affairs in biotech and has training in nutrition from Cornell University. Dr. Swathi has served as faculty and guest lectures at colleges and universities across the country. She is an advisor and consultant for a number of for-profit and nonprofit organizations aiming to make the world a healthier place for us to live–and thrive. She has been published in peer-reviewed academic journals and featured in Yahoo, mindbodygreen, Well+Good, Entrepreneur, Forbes Health, and more. In 2023, Dr. Swathi was voted one of the 50 Most Influential Leaders in Pharmacy. Connect with Dr. Swathi via: Email: swathimvaranasi@gmail.com  FB: Doctor Swathi  IG: @drswathivaranasi Linked In:Dr. Swathi Varanasi  Check out our earlier episode here: https://www.marinabuksov.com/s03e03-paving-the-unconventional-path-with-integrative-pharmacist-dr-swathi-varanasi/ 

In this candid and wide-ranging conversation, we sit down with Dr. Brian Schmutzler — anesthesiologist, social media educator, and Executive Vice President of Medical Affairs at CCI Anesthesia — to unpack what it really means to lead in modern anesthesia. From the realities of staffing rural hospitals without anesthesiologists to fighting burnout, navigating private equity, and fiercely defending provider scope and safety, Brian shares hard-earned insights from both clinical and corporate perspectives.We also dive into the power of humor and education on social media, his 108K-strong Instagram following, and how his content brings awareness, advocacy, and levity to patients and practitioners alike.If you're a CRNA, MD, administrator, or just someone trying to understand where anesthesia is headed — and how to lead within it — this is an episode you can't miss.Keywords:Leadership, Anesthesia, Social Media, Burnout, Independent PracticeSend us a textFollow us at:InstagramFacebookTwitter/X

Dr. Isabelle Raymond is an author and scientific leader in pharmaceutical and biotech industries, more recently working in beauty and wellness. She has authored over 80 publications and textbook chapters and books in several therapeutic fields including aesthetic medicine, dermatology, sleep disorders and pain management. She is currently the Head of Clinical and Medical Affairs at Nutrafol. She joins the show to discuss the hair growth cycle, how our hair changes throughout different stages of life, and why clinical research is essential when it comes to nutraceuticals.This episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct, or indirect financial interest in products, or services referred to in this episode.Visit Nutrafol.com and enter code BLONDE for $10 off your first month and free shipping. Visit masachips.com and use promo code BLONDE to get 20% off your first order.Visit justthrivehealth.com and save 20% with promo code WellVisit oneskin.co/well and use code WELL for 15% off your first order.Produced by Dear MediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.